Showing 1761-1770 of 10609 results for "".
Dealing with the Crazy Cost Curve in Dermatologic Drugs
https://practicaldermatology.com/topics/practice-management/dealing-with-the-crazy-cost-curve-in-dermatologic-drugs/20376/Dermatologists, desperate for relief from the forces that have sent prices skyrocketing, are pushing for reform or exploring other options.Atopic Dermatitis: A Review of Common Comorbidities
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-a-review-of-common-comorbidities/23352/It is important to acknowledge and identify comorbidities to successfully manage AD and improve patient quality of life.In the Pipeline: New Approaches to Vitiligo, Congenital Ichthyosis, and More
https://practicaldermatology.com/topics/pigmentary-disorders/in-the-pipeline-new-approaches-to-vitiligo-congenital-ichthyosis-and-more/23714/Inflammatory diseases with few or no specific treatments may soon have approved interventions.A Definitive Guide to Recognizing and Treating “Maskne”
https://practicaldermatology.com/columns/clinical-focus-1/a-definitive-guide-to-recognizing-and-treating-maskne/23520/Practical Dermatology® magazine’s resident acne columnist offers step-by-step guidance.Navigating Industry: Tips for Successful Relationships and Partnerships
https://practicaldermatology.com/issues/january-february-2025/navigating-industry-tips-for-successful-relationships-and-partnerships/32976/Dermatology is no longer confined to the physician-patient interaction in a busy clinic, private practice office, or academic center.How do barrier dysfunction proteins interact with immune dysregulation to sustain AD?
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/how-do-barrier-dysfunction-proteins-interact-with-immune-dysregulation-to-sustain-ad/56736/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses whether barrier dysfunction drives inflammation and immune dysregulation, or vice versa, or both, in atopic dermatitis.Advances in Topicals for Skin Conditions
https://practicaldermatology.com/topics/psoriasis/advances-in-topicals-for-skin-conditions/20197/There are more topicals available today than ever before for acne, rosacea, and psoriasis, and even more are coming down the pike. Larry Green, MD, reviews the current topical landscape in dermatology and previews what’s in the pipeline.See how ILUMYA™ works
https://practicaldermatology.com/topics/psoriasis/see-how-ilumya-works/19857/Learn about the immunopathogenesis of plaque psoriasis, and how the IL-23 inhibitor ILUMYA™ controls the release of key cytokines to continuously maintain immune homeostasis.Spectra VRM II Tattoo Removal
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/tattoo-removal/19524/Description of pulse duration and wavelength for chromophores and demonstrates tattoo removal in African-American patient.DermWire TV Extra: Dr. Bunick on BPO Study
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-dr-bunick-bpo-study/29165/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the new Journal of Investigative Dermatology article he co-authored, "Evaluation of Benzene Presence and Formulation in Benzoyl Peroxide Drug Products."